Home The Word Brain Fast Track My Amedeo FAQ About Flying Publisher   

Fast Track

The Word Brain 2015Free PDF | Print | Web
A short guide to fast language learning

Free Abstracts

  Nuclear Medicine

  Free Subscription


Articles published in Neurology

Retrieve available abstracts of 129 articles:
HTML format
Text format



Single Articles


    August 2015
  1. ALPERT JN, Saidha S, Al-Louzi O
    Biopsy-negative PET-positive giant-cell arteritis.
    Neurology. 2015;85:743.
    PubMed     Text format    


  2. NIRENBERG MJ
    Preoperative factors of apathy in subthalamic stimulated Parkinson disease: A PET study.
    Neurology. 2015;85:483.
    PubMed     Text format    


    July 2015
  3. LIU E, Schmidt ME, Margolin R, Sperling R, et al
    Amyloid-beta 11C-PiB-PET imaging results from 2 randomized bapineuzumab phase 3 AD trials.
    Neurology. 2015 Jul 24. pii: 10.1212/WNL.0000000000001877.
    PubMed     Text format     Abstract available


    June 2015
  4. COSGROVE J, Jamieson S, Chowdhury FU
    Teaching NeuroImages: Hypometabolism of the primary motor cortex in primary lateral sclerosis: The stripe sign.
    Neurology. 2015;84:e206.
    PubMed     Text format    


  5. JENNINGS D, Siderowf A, Stern M, Seibyl J, et al
    Author Response.
    Neurology. 2015;84:2292.
    PubMed     Text format    


  6. MULLER ML, Albin RL, Bohnen NI, Jennings D, et al
    Imaging prodromal Parkinson disease: The Parkinson Associated Risk Syndrome Study.
    Neurology. 2015;84:2292.
    PubMed     Text format    


    May 2015
  7. BRIDEL C, Garibotto V
    Teaching NeuroImages: Drug-induced parkinsonism with asymmetrical putaminal DaT binding.
    Neurology. 2015;84:e159.
    PubMed     Text format    


  8. LEVENTER RJ, Scerri T, Marsh AP, Pope K, et al
    Hemispheric cortical dysplasia secondary to a mosaic somatic mutation in MTOR.
    Neurology. 2015;84:2029-32.
    PubMed     Text format     Abstract available


  9. CAMPBELL MC, Koller JM, Snyder AZ, Buddhala C, et al
    CSF proteins and resting-state functional connectivity in Parkinson disease.
    Neurology. 2015 May 15. pii: 10.1212/WNL.0000000000001681.
    PubMed     Text format     Abstract available


  10. GROWDON ME, Schultz AP, Dagley AS, Amariglio RE, et al
    Odor identification and Alzheimer disease biomarkers in clinically normal elderly.
    Neurology. 2015 May 1. pii: 10.1212/WNL.0000000000001614.
    PubMed     Text format     Abstract available


    April 2015
  11. IKAWA M, Okazawa H, Tsujikawa T, Matsunaga A, et al
    Increased oxidative stress is related to disease severity in the ALS motor cortex: A PET study.
    Neurology. 2015 Apr 22. pii: 10.1212/WNL.0000000000001588.
    PubMed     Text format     Abstract available


    January 2015
  12. SUCHORSKA B, Jansen NL, Linn J, Kretzschmar H, et al
    Biological tumor volume in 18FET-PET before radiochemotherapy correlates with survival in GBM.
    Neurology. 2015 Jan 21. pii: 10.1212/WNL.0000000000001262.
    PubMed     Text format     Abstract available


  13. APOSTOLOVA LG, Hwang KS, Avila D, Elashoff D, et al
    Brain amyloidosis ascertainment from cognitive, imaging, and peripheral blood protein measures.
    Neurology. 2015 Jan 21. pii: 10.1212/WNL.0000000000001231.
    PubMed     Text format     Abstract available


  14. JENNINGS D, Seibyl J, Sabbagh M, Lai F, et al
    Age dependence of brain beta-amyloid deposition in Down syndrome: An [18F]florbetaben PET study.
    Neurology. 2015 Jan 7. pii: 10.1212/WNL.0000000000001212.
    PubMed     Text format     Abstract available


  15. WING YK, Lam SP, Zhang J, Leung E, et al
    Reduced striatal dopamine transmission in REM sleep behavior disorder comorbid with depression.
    Neurology. 2015 Jan 7. pii: 10.1212/WNL.0000000000001215.
    PubMed     Text format     Abstract available


    November 2014
  16. SOUSSAN M, Medjoul A, Badelon I, Guillot A, et al
    IgG4-related diffuse perineural disease.
    Neurology. 2014;83:1877-8.
    PubMed     Text format    


  17. LOPEZ OL, Klunk WE, Mathis C, Coleman RL, et al
    Amyloid, neurodegeneration, and small vessel disease as predictors of dementia in the oldest-old.
    Neurology. 2014;83:1804-11.
    PubMed     Text format     Abstract available


  18. RAMAN MR, Wiste HJ, Senjem ML, Ward CP, et al
    Spontaneous amyloid-related imaging abnormalities in a cognitively normal adult.
    Neurology. 2014;83:1771-2.
    PubMed     Text format    


    October 2014
  19. JENNINGS D, Siderowf A, Stern M, Seibyl J, et al
    Imaging prodromal Parkinson disease: The Parkinson Associated Risk Syndrome Study.
    Neurology. 2014 Oct 8. pii: 10.1212/WNL.0000000000000960.
    PubMed     Text format     Abstract available


  20. AL-LOUZI O, Hauptman H, Saidha S
    Biopsy-negative PET-positive giant-cell arteritis.
    Neurology. 2014 Oct 1. pii: 10.1212/WNL.0000000000000940.
    PubMed     Text format    


    September 2014
  21. COHEN-AUBART F, Emile JF, Maksud P, Galanaud D, et al
    Marked efficacy of vemurafenib in suprasellar Erdheim-Chester disease.
    Neurology. 2014;83:1294-6.
    PubMed     Text format    


  22. ROBERT GH, Le Jeune F, Lozachmeur C, Drapier S, et al
    Preoperative factors of apathy in subthalamic stimulated Parkinson disease: A PET study.
    Neurology. 2014 Sep 24. pii: 10.1212/WNL.0000000000000941.
    PubMed     Text format     Abstract available


  23. HEMB M, Paglioli E, Dubeau F, Andermann F, et al
    "Mirror EPC": Epilepsia partialis continua shifting sides after rolandic resection in dysplasia.
    Neurology. 2014 Sep 12. pii: 10.1212/WNL.0000000000000878.
    PubMed     Text format     Abstract available


  24. BAUER M, Karch R, Zeitlinger M, Liu J, et al
    In vivo P-glycoprotein function before and after epilepsy surgery.
    Neurology. 2014 Sep 3. pii: 10.1212/WNL.0000000000000858.
    PubMed     Text format     Abstract available


    August 2014
  25. GRAFF-RADFORD J, Murray ME, Lowe VJ, Boeve BF, et al
    Dementia with Lewy bodies: basis of cingulate island sign.
    Neurology. 2014;83:801-9.
    PubMed     Text format     Abstract available


  26. PAGANI M, Chio A, Valentini MC, Oberg J, et al
    Functional pattern of brain FDG-PET in amyotrophic lateral sclerosis.
    Neurology. 2014 Aug 13. pii: 10.1212/WNL.0000000000000792.
    PubMed     Text format     Abstract available


  27. SALSANO E, Marotta G, Manfredi V, Giovagnoli AR, et al
    Brain fluorodeoxyglucose PET in adrenoleukodystrophy.
    Neurology. 2014 Aug 6. pii: 10.1212/WNL.0000000000000770.
    PubMed     Text format     Abstract available


    July 2014
  28. VILLENEUVE S, Reed BR, Madison CM, Wirth M, et al
    Vascular risk and Abeta interact to reduce cortical thickness in AD vulnerable brain regions.
    Neurology. 2014;83:40-7.
    PubMed     Text format     Abstract available


    June 2014
  29. LOWE VJ, Weigand SD, Senjem ML, Vemuri P, et al
    Association of hypometabolism and amyloid levels in aging, normal subjects.
    Neurology. 2014;82:1959-67.
    PubMed     Text format     Abstract available


    May 2014
  30. LEWITT PA, Mouradian MM
    Predicting the development of levodopa-induced dyskinesias: a presynaptic mechanism?
    Neurology. 2014;82:1574-5.
    PubMed     Text format     Abstract available


  31. LEYTON CE, Ballard KJ, Piguet O, Hodges JR, et al
    Phonologic errors as a clinical marker of the logopenic variant of PPA.
    Neurology. 2014;82:1620-7.
    PubMed     Text format     Abstract available


  32. JACK CR JR, Wiste HJ, Knopman DS, Vemuri P, et al
    Rates of beta-amyloid accumulation are independent of hippocampal neurodegeneration.
    Neurology. 2014;82:1605-12.
    PubMed     Text format     Abstract available


    April 2014
  33. CHROININ DN, Marnane M, Akijian L, Merwick A, et al
    Serum lipids associated with inflammation-related PET-FDG uptake in symptomatic carotid plaque.
    Neurology. 2014.
    PubMed     Text format     Abstract available


  34. JICKLING GC, Chaturvedi S
    Carotid plaque inflammation in stroke assessed by PET: A burning issue?
    Neurology. 2014.
    PubMed     Text format     Abstract available


  35. HONG JY, Oh JS, Lee I, Sunwoo MK, et al
    Presynaptic dopamine depletion predicts levodopa-induced dyskinesia in de novo Parkinson disease.
    Neurology. 2014.
    PubMed     Text format     Abstract available


    March 2014
  36. KIM GH, Lee JH, Seo SW, Ye BS, et al
    Seoul criteria for PiB(-) subcortical vascular dementia based on clinical and MRI variables.
    Neurology. 2014.
    PubMed     Text format     Abstract available


  37. YATES PA, Desmond PM, Phal PM, Steward C, et al
    Incidence of cerebral microbleeds in preclinical Alzheimer disease.
    Neurology. 2014.
    PubMed     Text format     Abstract available


    February 2014
  38. TONDER M, Rushing EJ, Grotzer M, Surucu O, et al
    Clinical reasoning: a 30-year-old woman with recurrent seizures and a cerebral lesion progressing over 2 decades.
    Neurology. 2014;82:e56-60.
    PubMed     Text format    


  39. HOLTBERND F, Gagnon JF, Postuma RB, Ma Y, et al
    Abnormal metabolic network activity in REM sleep behavior disorder.
    Neurology. 2014;82:620-7.
    PubMed     Text format     Abstract available


  40. SULC V, Stykel S, Hanson DP, Brinkmann BH, et al
    Statistical SPECT processing in MRI-negative epilepsy surgery.
    Neurology. 2014.
    PubMed     Text format     Abstract available


  41. HENRY TR
    Resecting without detecting the lesion in extratemporal lobe epilepsy?
    Neurology. 2014.
    PubMed     Text format     Abstract available


  42. HANNAH-SHMOUNI F, Matiello M, Russell DS, Hasbani MJ, et al
    Teaching Video NeuroImages: Spasmodic dysphonia preceding idiopathic parkinsonism.
    Neurology. 2014;82:e55.
    PubMed     Text format     Abstract available


    January 2014
  43. SHIMA S, Kawamura N, Ishikawa T, Masuda H, et al
    Anti-neutral glycolipid antibodies in encephalomyeloradiculoneuropathy.
    Neurology. 2014;82:114-8.
    PubMed     Text format     Abstract available


    December 2013
  44. SANCHEZ-JUAN P, Ghosh PM, Hagen J, Gesierich B, et al
    Practical utility of amyloid and FDG-PET in an academic dementia center.
    Neurology. 2013.
    PubMed     Text format     Abstract available


  45. AHMAD R, Bourgeois S, Postnov A, Schmidt ME, et al
    PET imaging shows loss of striatal PDE10A in patients with Huntington disease.
    Neurology. 2013.
    PubMed     Text format     Abstract available


    November 2013
  46. KLUNK WE, Perani D
    Amyloid and neurodegeneration: converging and diverging paths.
    Neurology. 2013;81:1728-9.
    PubMed     Text format     Abstract available


  47. BERGNER CG, Lang C, Spreer A, Bahr M, et al
    Teaching NeuroImages: Ma2 encephalitis presenting as acute panhypopituitarism in a young man.
    Neurology. 2013;81:e146-7.
    PubMed     Text format     Abstract available


    October 2013
  48. JACK CR JR , Wiste HJ, Weigand SD, Knopman DS, et al
    Amyloid-first and neurodegeneration-first profiles characterize incident amyloid PET positivity.
    Neurology. 2013.
    PubMed     Text format     Abstract available


  49. WEIJENBERG A , van Dijk JM, Pruim J, Luijckx GJ, et al
    Teaching NeuroImages: FDG-PET imaging in primary diffuse leptomeningeal gliomatosis.
    Neurology. 2013;81:e119-20.
    PubMed     Text format     Abstract available


  50. BALLARD C , Grimmer T
    Improving diagnosis of possible DLB: Is there a role for MIBG myocardial scintigraphy?
    Neurology. 2013.
    PubMed     Text format     Abstract available


  51. ODA H , Ishii K, Terashima A, Shimada KI, et al
    Myocardial scintigraphy may predict the conversion to probable dementia with Lewy bodies.
    Neurology. 2013.
    PubMed     Text format     Abstract available


  52. JACOVA C, Hsiung GY, Tawankanjanachot I, Dinelle K, et al
    Anterior brain glucose hypometabolism predates dementia in progranulin mutation carriers.
    Neurology. 2013;81:1322-31.
    PubMed     Text format     Abstract available



  53. The history of cerebral PET scanning: From physiology to cutting-edge technology.
    Neurology. 2013;81:1275.
    PubMed     Text format     Abstract available


  54. SINGHAL T , Okun M, Portnow L, Vaillancourt D, et al
    The history of cerebral PET scanning: From physiology to cutting-edge technology.
    Neurology. 2013;81:1275.
    PubMed     Text format     Abstract available


    September 2013
  55. BOHNEN NI , Frey KA, Studenski S, Kotagal V, et al
    Gait speed in Parkinson disease correlates with cholinergic degeneration.
    Neurology. 2013.
    PubMed     Text format     Abstract available


  56. RABINOVICI GD , Boeve BF
    Imaging prodromal FTD: Seeing the future through PET crystals.
    Neurology. 2013.
    PubMed     Text format     Abstract available


    August 2013
  57. PATEL NK , Pavese N, Javed S, Hotton GR, et al
    Benefits of putaminal gdnf infusion in parkinson disease are maintained after gdnf cessation.
    Neurology. 2013.
    PubMed     Text format     Abstract available


  58. SHAMY MC , Jaigobin CS
    The complexities of acute stroke decision-making: A survey of neurologists.
    Neurology. 2013.
    PubMed     Text format     Abstract available


    July 2013
  59. FRISONI GB , Bocchetta M, Chetelat G, Rabinovici GD, et al
    Imaging markers for Alzheimer disease: Which vs how.
    Neurology. 2013;81:487-500.
    PubMed     Text format     Abstract available


  60. KALRA VB , Rao B, Malhotra A
    Teaching NeuroImages: Perfusion imaging of cerebral hyperperfusion syndrome following revascularization.
    Neurology. 2013;81:e25-6.
    PubMed     Text format     Abstract available


  61. JOSEPHS KA , Duffy JR, Strand EA, Machulda MM, et al
    Syndromes dominated by apraxia of speech show distinct characteristics from agrammatic PPA.
    Neurology. 2013;81:337-45.
    PubMed     Text format     Abstract available


  62. CHUGANI HT , Luat AF, Kumar A, Govindan R, et al
    alpha-[11C]-Methyl-L-tryptophan-PET in 191 patients with tuberous sclerosis complex.
    Neurology. 2013.
    PubMed     Text format     Abstract available


  63. CAMPBELL MC , Markham J, Flores H, Hartlein JM, et al
    Principal component analysis of PiB distribution in Parkinson and Alzheimer diseases.
    Neurology. 2013.
    PubMed     Text format     Abstract available


  64. TOLEDANO M , Siddiqui MA, Thompson CA, Garza I, et al
    Teaching NeuroImages: Diagnostic utility of FDG-PET in neurolymphomatosis.
    Neurology. 2013;81:e3.
    PubMed     Text format     Abstract available


    May 2013
  65. LOANE C , Wu K, Bain P, Brooks DJ, et al
    Serotonergic loss in motor circuitries correlates with severity of action-postural tremor in PD.
    Neurology. 2013;80:1850-5.
    PubMed     Text format     Abstract available


  66. LOWE VJ , Peller PJ, Weigand SD, Montoya Quintero C, et al
    Application of the National Institute on Aging-Alzheimer's Association AD criteria to ADNI.
    Neurology. 2013.
    PubMed     Text format     Abstract available


    April 2013
  67. SNITZ BE , Weissfeld LA, Lopez OL, Kuller LH, et al
    Cognitive trajectories associated with beta-amyloid deposition in the oldest-old without dementia.
    Neurology. 2013;80:1378-84.
    PubMed     Text format     Abstract available


  68. HEDDEN T , Oh H, Younger AP, Patel TA, et al
    Meta-analysis of amyloid-cognition relations in cognitively normal older adults.
    Neurology. 2013;80:1341-8.
    PubMed     Text format     Abstract available


    March 2013
  69. BURNS CM , Chen K, Kaszniak AW, Lee W, et al
    Higher serum glucose levels are associated with cerebral hypometabolism in Alzheimer regions.
    Neurology. 2013.
    PubMed     Text format     Abstract available


  70. HENRY TR , Juhasz C
    Serotonergic PET in temporal lobe epilepsy: Biomarking or etiologic mapping?
    Neurology. 2013.
    PubMed     Text format     Abstract available


  71. MARTINEZ A , Finegersh A, Cannon DM, Dustin I, et al
    The 5-HT1A receptor and 5-HT transporter in temporal lobe epilepsy.
    Neurology. 2013.
    PubMed     Text format     Abstract available


  72. EWERS M , Insel PS, Stern Y, Weiner MW, et al
    Cognitive reserve associated with FDG-PET in preclinical Alzheimer disease.
    Neurology. 2013.
    PubMed     Text format     Abstract available


  73. O'TOOLE O , Murphy R, Tracy JA, McKeon A, et al
    Teaching NeuroImages: PET-CT hypermetabolism paralleling muscle hyperactivity in stiff-person syndrome.
    Neurology. 2013;80:e109.
    PubMed     Text format     Abstract available


  74. PORTNOW LH , Vaillancourt DE, Okun MS
    The history of cerebral PET scanning: From physiology to cutting-edge technology.
    Neurology. 2013;80:952-6.
    PubMed     Text format     Abstract available


  75. JACK CR JR , Wiste HJ, Lesnick TG, Weigand SD, et al
    Brain beta-amyloid load approaches a plateau.
    Neurology. 2013;80:890-6.
    PubMed     Text format     Abstract available


    February 2013
  76. BECKER-BENSE S , Buchholz HG, Best C, Schreckenberger M, et al
    Vestibular compensation in acute unilateral medullary infarction: FDG-PET study.
    Neurology. 2013.
    PubMed     Text format     Abstract available


  77. ZWERGAL A , la Fougere C, Lorenzl S, Rominger A, et al
    Functional disturbance of the locomotor network in progressive supranuclear palsy.
    Neurology. 2013;80:634-41.
    PubMed     Text format     Abstract available


    January 2013
  78. CARBON M , Raymond D, Ozelius L, Saunders-Pullman R, et al
    Metabolic changes in DYT11 myoclonus-dystonia.
    Neurology. 2013;80:385-91.
    PubMed     Text format     Abstract available


  79. OSSENKOPPELE R , van der Flier WM, Zwan MD, Adriaanse SF, et al
    Differential effect of APOE genotype on amyloid load and glucose metabolism in AD dementia.
    Neurology. 2013;80:359-65.
    PubMed     Text format     Abstract available


  80. YOON CW , Shin JS, Kim HJ, Cho H, et al
    Cognitive deficits of pure subcortical vascular dementia vs Alzheimer disease: PiB-PET-based study.
    Neurology. 2013.
    PubMed     Text format     Abstract available


  81. SIERRA M , Sanchez-Juan P, Martinez-Rodriguez MI, Gonzalez-Aramburu I, et al
    Olfaction and imaging biomarkers in premotor LRRK2 G2019S-associated Parkinson disease.
    Neurology. 2013.
    PubMed     Text format     Abstract available


  82. WU MC , Yen RF, Lin CH, Wu RM, et al
    Hemiballism in a patient with parietal lobe infarction.
    Neurology. 2013;80:e22.
    PubMed     Text format     Abstract available


  83. MOOSA AN , Gupta A, Jehi L, Marashly A, et al
    Longitudinal seizure outcome and prognostic predictors after hemispherectomy in 170 children.
    Neurology. 2013;80:253-60.
    PubMed     Text format     Abstract available


    December 2012
  84. MCMILLAN CT , Avants B, Irwin DJ, Toledo JB, et al
    Can MRI screen for CSF biomarkers in neurodegenerative disease?
    Neurology. 2012.
    PubMed     Text format     Abstract available


  85. GOMPERTS SN , Locascio JJ, Rentz D, Santarlasci A, et al
    Amyloid is linked to cognitive decline in patients with Parkinson disease without dementia.
    Neurology. 2012.
    PubMed     Text format     Abstract available


  86. DANG-VU TT , Gagnon JF, Vendette M, Soucy JP, et al
    Hippocampal perfusion predicts impending neurodegeneration in REM sleep behavior disorder.
    Neurology. 2012;79:2302-6.
    PubMed     Text format     Abstract available


    October 2012
  87. HABA-RUBIO J , Prior JO, Guedj E, Tafti M, et al
    Kleine-Levin syndrome: Functional imaging correlates of hypersomnia and behavioral symptoms.
    Neurology. 2012.
    PubMed     Text format     Abstract available


  88. XIE T , Warnke P, Kang UJ, de la Fuente-Fernandez R, et al
    Role of DaTSCAN and clinical diagnosis in Parkinson disease.
    Neurology. 2012;79:1744.
    PubMed     Text format    


  89. LIM YY , Ellis KA, Pietrzak RH, Ames D, et al
    Stronger effect of amyloid load than APOE genotype on cognitive decline in healthy older adults.
    Neurology. 2012;79:1645-52.
    PubMed     Text format     Abstract available


  90. NISTICO R , Pirritano D, Novellino F, Salsone M, et al
    Blink reflex recovery cycle in patients with essential tremor associated with resting tremor.
    Neurology. 2012;79:1490-5.
    PubMed     Text format     Abstract available


    September 2012
  91. KALAMANGALAM GP , Velur P
    Teaching NeuroImages: Hemispheric epilepsy.
    Neurology. 2012;79:e111.
    PubMed     Text format    


  92. KNOPMAN DS
    Subjective cognitive impairment: fickle but fateful.
    Neurology. 2012;79:1308-9.
    PubMed     Text format    


  93. SCHEEF L , Spottke A, Daerr M, Joe A, et al
    Glucose metabolism, gray matter structure, and memory decline in subjective memory impairment.
    Neurology. 2012;79:1332-9.
    PubMed     Text format     Abstract available


  94. LO RY , Jagust WJ
    Vascular burden and Alzheimer disease pathologic progression.
    Neurology. 2012.
    PubMed     Text format     Abstract available


  95. HUANG JF , Aksamit AJ, Staff NP
    MRI and PET imaging discordance in neurosarcoidosis.
    Neurology. 2012;79:1070.
    PubMed     Text format    


    August 2012
  96. EDER KE , Haussen DC, Searls DE, Henninger N, et al
    Reverberating TCD flow pattern in brain death.
    Neurology. 2012;79:e79.
    PubMed     Text format    


  97. HELLWIG S , Amtage F, Kreft A, Buchert R, et al
    [18F]FDG-PET is superior to [123I]IBZM-SPECT for the differential diagnosis of parkinsonism.
    Neurology. 2012.
    PubMed     Text format     Abstract available


  98. BOHNEN NI , Minoshima S
    FDG-PET and molecular brain imaging in the movement disorders clinic.
    Neurology. 2012.
    PubMed     Text format     Abstract available


  99. ROBERT G , Le Jeune F, Lozachmeur C, Drapier S, et al
    Apathy in patients with Parkinson disease without dementia or depression: A PET study.
    Neurology. 2012.
    PubMed     Text format     Abstract available


    July 2012
  100. GRAFF-RADFORD J , Drubach DA, Strand EA, Josephs KA, et al
    Fluorodeoxyglucose F18 PET in progressive emotional dysprosody.
    Neurology. 2012.
    PubMed     Text format     Abstract available


  101. DORAISWAMY PM , Sperling RA, Coleman RE, Johnson KA, et al
    Amyloid-beta assessed by florbetapir F 18 PET and 18-month cognitive decline: A multicenter study.
    Neurology. 2012.
    PubMed     Text format     Abstract available


  102. CALABRESI PA , Bohnen NI
    Can PET imaging tell us what's the matter with the gray matter in multiple sclerosis?
    Neurology. 2012.
    PubMed     Text format     Abstract available


  103. POLITIS M , Giannetti P, Su P, Turkheimer F, et al
    Increased PK11195 PET binding in the cortex of patients with MS correlates with disability.
    Neurology. 2012.
    PubMed     Text format     Abstract available


    June 2012
  104. SCHOLL M , Wall A, Thordardottir S, Ferreira D, et al
    Low PiB PET retention in presence of pathologic CSF biomarkers in Arctic APP mutation carriers.
    Neurology. 2012.
    PubMed     Text format     Abstract available


    May 2012
  105. PRUSS H , Holtje M, Maier N, Gomez A, et al
    IgA NMDA receptor antibodies are markers of synaptic immunity in slow cognitive impairment.
    Neurology. 2012;78:1743-53.
    PubMed     Text format     Abstract available


  106. KOSTOPOULOS P , Walter S, Haass A, Papanagiotou P, et al
    Mobile stroke unit for diagnosis-based triage of persons with suspected stroke.
    Neurology. 2012.
    PubMed     Text format     Abstract available


  107. PAYABVASH S , Souza LC, Kamalian S, Wang Y, et al
    Location-weighted CTP analysis predicts early motor improvement in stroke: A preliminary study.
    Neurology. 2012.
    PubMed     Text format     Abstract available


  108. HAREL NY , Tseng BY
    Cerebral perfusion in acute stroke prognostication: Go with the flow, or know with the quo?
    Neurology. 2012.
    PubMed     Text format     Abstract available


  109. BAJAJ NP
    Role of DaTSCAN and clinical diagnosis in PD.
    Neurology. 2012;78:1538-9.
    PubMed     Text format    


  110. KNOPMAN DS , Jack CR Jr, Wiste HJ, Weigand SD, et al
    Short-term clinical outcomes for stages of NIA-AA preclinical Alzheimer disease.
    Neurology. 2012.
    PubMed     Text format     Abstract available


    April 2012
  111. MCDADE E , Boeve BF, Burrus TM, Boot BP, et al
    Similar clinical and neuroimaging features in monozygotic twin pair with mutation in progranulin.
    Neurology. 2012;78:1245-9.
    PubMed     Text format     Abstract available


  112. POSTON KL , Tang CC, Eckert T, Dhawan V, et al
    Network correlates of disease severity in multiple system atrophy.
    Neurology. 2012;78:1237-44.
    PubMed     Text format     Abstract available


  113. LO RY , Jagust WJ
    Predicting missing biomarker data in a longitudinal study of Alzheimer disease.
    Neurology. 2012.
    PubMed     Text format     Abstract available


  114. SCHOTT JM , Bartlett JW
    Investigating missing data in Alzheimer disease studies.
    Neurology. 2012.
    PubMed     Text format     Abstract available


    March 2012
  115. PERLMUTTER JS , Eidelberg D
    To scan or not to scan: DaT is the question.
    Neurology. 2012;78:688-9.
    PubMed     Text format    


    February 2012
  116. CHETELAT G , Villemagne VL, Villain N, Jones G, et al
    Accelerated cortical atrophy in cognitively normal elderly with high beta-amyloid deposition.
    Neurology. 2012;78:477-84.
    PubMed     Text format     Abstract available


  117. DE LA FUENTE-FERNANDEZ R
    Role of DaTSCAN and clinical diagnosis in Parkinson disease.
    Neurology. 2012.
    PubMed     Text format     Abstract available


    January 2012
  118. MARSHALL RS , Festa JR, Cheung YK, Chen R, et al
    Cerebral hemodynamics and cognitive impairment: baseline data from the RECON trial.
    Neurology. 2012;78:250-5.
    PubMed     Text format     Abstract available


  119. KANTARCI K , Lowe V, Przybelski SA, Weigand SD, et al
    APOE modifies the association between Abeta load and cognition in cognitively normal older adults.
    Neurology. 2012;78:232-40.
    PubMed     Text format     Abstract available


  120. AYRIGNAC X , Taieb G, Castelnovo G, Renard D, et al
    Cortical and cerebellar hypometabolism after bilateral antero-inferior cerebellar artery infarct.
    Neurology. 2012;78:69-70.
    PubMed     Text format    


    December 2011
  121. JOHNSON KA , Dickerson BC
    A tale of two tracers: the age of wisdom for dementia diagnosis?
    Neurology. 2011;77:2008-9.
    PubMed     Text format    


    November 2011
  122. RABINOVICI GD , Rosen HJ, Alkalay A, Kornak J, et al
    Amyloid vs FDG-PET in the differential diagnosis of AD and FTLD.
    Neurology. 2011.
    PubMed     Text format     Abstract available


  123. VIDONI ED , Townley RA, Honea RA, Burns JM, et al
    Alzheimer disease biomarkers are associated with body mass index.
    Neurology. 2011;77:1913-1920.
    PubMed     Text format     Abstract available


  124. CHEN Y , Wolk DA, Reddin JS, Korczykowski M, et al
    Voxel-level comparison of arterial spin-labeled perfusion MRI and FDG-PET in Alzheimer disease.
    Neurology. 2011.
    PubMed     Text format     Abstract available


  125. BRENNER SR , Racette BA, Criswell SR, Perlmutter JS, et al
    Reduced uptake of [18F]FDOPA PET in asymptomatic welders with occupational manganese exposure.
    Neurology. 2011;77:e120.
    PubMed     Text format    


  126. PEREZ DL , Larvie M, Acar D, Daffner K, et al
    Teaching NeuroImages: apathetic variant of frontotemporal dementia.
    Neurology. 2011;77:e117.
    PubMed     Text format    


    October 2011
  127. KIRMI O , Murphy E, Carecchio M, Sulkin T, et al
    Teaching NeuroImages: Progressive asymmetric parkinsonism and tendon xanthomas.
    Neurology. 2011;77:e97.
    PubMed     Text format    


  128. PAPPATA S , Santangelo G, Aarsland D, Vicidomini C, et al
    Mild cognitive impairment in drug-naive patients with PD is associated with cerebral hypometabolism.
    Neurology. 2011;77:1357-62.
    PubMed     Text format     Abstract available


    July 2011
  129. SEELAAR H , Papma JM, Garraux G, de Koning I, et al
    Brain perfusion patterns in familial frontotemporal lobar degeneration.
    Neurology. 2011;77:384-92.
    PubMed     Text format     Abstract available


Thank you for your interest in scientific medicine.


All AMEDEO services are free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Amedeo is a Flying Publisher website.

   Design: